Bresnahan unloaded Medicaid insurer stock, then voted to cut Medicaid

Weeks before Congress passed its One Big Beautiful Bill, slashing funding for Medicaid coverage across the United States, U.S. Rep. Rob Bresnahan (R-PA) sold stocks in nine companies that either provide Medicaid insurance coverage or could otherwise be affected by the bill. 

According to Quiver Quantitative, the stocks he sold on May 15, 2025 included:

• UNH (UnitedHealth, Medicaid provider): sold stock worth up to $50,000 
• CNC (Centene Corporation, Medicaid provider): sold stock worth up to $15,000
• CVS (CVS Health, Medicaid provider and drug stores): sold stock worth up to $15,000
• ELV (Elevance Health, Medicaid provider): sold up to $50,000 in stock
• HUM (Humana Inc, Medicaid provider): sold up to $15,000 in stock
• CRL (Charles River Laboratories, a drug research company): sold stock worth up to $15,000
• COO (CooperCompanies, a medical device company): sold stock worth up to $15,000
• LH (Labcorp Holdings, lab diagnostics and drug development): sold up to $15,000 in stock
• DOC (Healthpeak Properties, a health care real estate investment trust): sold up to $15,000 in stock

UnitedHealth, Centene Corp, CVS Health, Elevance Health and Humana Inc. oversee at least half of all Medicaid managed care organizations, according to the health care policy research organization KFF.

Meanwhile, Charles River Laboratories and Labcorp Holdings are drug development and drug manufacturing companies. Those companies could be affected by the bill’s new rules for negotiating price caps for pharmaceuticals covered by Medicaid, reducing the amount they could charge for prescriptions.

Cooper Companies is a medical device company with two branches, one that specializes in contact lenses and another that focuses on fertility devices and treatment. 

Healthpeak Properties develops and owns research labs and outpatient healthcare facilities. 

Bresnahan’s stock sales and vote to approve the One Big Beautiful Bill came after a warning he gave in February 2025 against a budget resolution that would slash benefits for his constituents, and said he would vote no on the measure. At the time, the resolution was predicted to give an additional $900 billion to the wealthy and $1 trillion in cuts to Medicaid and food stamps.

The Republican also ran for election on a campaign promise to ban congressional stock trading. But in August 2025, he went back on that promise and said he will keep trading, as otherwise he would “lose money and go broke.” 

Tiffany Muller, president of the End Citizens United political action committee, said Bresnahan’s investment timeline shows that he “made sure his stock portfolio was protected right before he voted to gut Medicaid and the ACA.”

“He can claim that it was all a coincidence until he’s blue in the face, but no amount of verbal gymnastics can erase the fact that it appears he used insider information to protect his personal wealth,” she said in a statement. “His investments escaped the damage. His constituents weren’t so lucky.”

Bresnahan faces Democratic challenger Paige Cognetti in Pennsylvania’s 8th Congressional District next month. Heartland Signal reached out to Bresnahan’s and Cognetti’s campaigns for comments on this matter. Neither responded.